174 related articles for article (PubMed ID: 147324)
1. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
[TBL] [Abstract][Full Text] [Related]
2. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
[TBL] [Abstract][Full Text] [Related]
3. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
[TBL] [Abstract][Full Text] [Related]
4. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.
Engel AG; Lambert EH; Howard FM
Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
Fumagalli G; Engel AG; Lindstrom J
J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
[TBL] [Abstract][Full Text] [Related]
6. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
[TBL] [Abstract][Full Text] [Related]
7. The immunopathology of acquired myasthenia gravis.
Engel AG; Sahashi K; Fumagalli G
Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
[TBL] [Abstract][Full Text] [Related]
8. The immunopathology of myasthenia gravis.
Engel AG
Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
[No Abstract] [Full Text] [Related]
9. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis.
Sahashi K; Engel AG; Lambert EH; Howard FM
J Neuropathol Exp Neurol; 1980 Mar; 39(2):160-72. PubMed ID: 7373347
[TBL] [Abstract][Full Text] [Related]
10. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
Engel AG; Lindstrom JM; Lambert EH; Lennon VA
Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural study of neuromuscular junctions in experimental autoimmune myasthenia gravis (EAMG) in rabbits.
Arizono N; Takeoka O; Hasegawa M; Yonezawa T; Yamaguchi K
Acta Pathol Jpn; 1985 May; 35(3):621-9. PubMed ID: 4036600
[TBL] [Abstract][Full Text] [Related]
13. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.
Lennon VA; Seybold ME; Lindstrom JM; Cochrane C; Ulevitch R
J Exp Med; 1978 Apr; 147(4):973-83. PubMed ID: 206648
[TBL] [Abstract][Full Text] [Related]
14. The immunopathology of myasthenia gravis.
Lennon VA
Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
[TBL] [Abstract][Full Text] [Related]
16. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
Graus YM; Verschuuren JJ; Spaans F; Jennekens F; van Breda Vriesman PJ; De Baets MH
J Immunol; 1993 May; 150(9):4093-103. PubMed ID: 8386206
[TBL] [Abstract][Full Text] [Related]
17. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
18. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.
Deng C; Goluszko E; Tüzün E; Yang H; Christadoss P
J Immunol; 2002 Jul; 169(2):1077-83. PubMed ID: 12097416
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.
Tsujihata M; Yoshimura T; Satoh A; Kinoshita I; Matsuo H; Mori M; Nagataki S
Neurology; 1989 Oct; 39(10):1359-63. PubMed ID: 2797459
[TBL] [Abstract][Full Text] [Related]
20. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]